SecBot SecBot
424B5 ·Filed Nov 16, 2026

MEDS

DataMeds AI, Inc.
BEARISH
Impact 5/10
Horizonweeks Processed1d 11h ago SEC0001493152-26-051966
Notable filing: 424B5
Actionable Insight ▼ Bearish

The ATM program gives DataMeds the capacity to sell stock continuously at market prices, which will likely pressure the stock given the company's small market cap and high volatility. Monitor quarterly disclosures for actual shares sold under the program and watch for any further deterioration in operating results that could accelerate the pace of ATM sales.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+1
Entry
$0.6421
T+0 close · Nov 16, 2026 · via day close
Latest settled
−0.28%
T+1 · $0.6403
Vs SPY
+0.73%
α at T+1
Next horizon
T+5
in 6d
  1. T+0 · Nov 16 $0.6421entry
  2. T+1 · 11h ago −0.28%α +0.73% · $0.6403
  3. T+5 · in 6d Pending
  4. T+20 · in 28d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

DataMeds AI filed a 424B5 prospectus supplement establishing an at-the-market (ATM) equity offering program of up to $10,003,649 in common stock, with Dawson James Securities as sales agent. The filing comes three days after the company reported Q3 2026 results showing a 50% sequential revenue increase but an 11.4% YoY revenue decline and a $3.4M operating loss, suggesting the capital raise is driven by ongoing cash needs.

Key Financial Metrics

Offering Size
$10.0M
Dilution
236%
Underwriters
Dawson James Securities, Inc.

Key Facts

  • ATM sales agreement with Dawson James Securities for up to $10,003,649 in common stock
  • 3.0% commission on gross proceeds to sales agent
  • 5,724,857 shares outstanding as of November 13, 2026
  • Maximum potential dilution: up to 13,518,445 shares at $0.74/share (236% of current shares outstanding)
  • Filed 3 days after Q3 2026 earnings showing 11.4% YoY revenue decline and $3.4M operating loss
  • Proceeds intended for debt repayment, working capital and general corporate purposes
  • Company has $4M market cap with 8.3% normal daily volatility
  • 16 offering/registration filings in last 24 months, indicating frequent capital needs

Financial Impact

Up to $10,003,649 in potential equity sales, representing 250% of current market cap; maximum dilution of 236% of shares outstanding

dilutionshare countmarket cap

Risk Factors

  • ATM sales could cause significant dilution given the program size (250% of market cap)
  • Company has negative tangible book value of $(28.9) million
  • Frequent capital raises (16 filings in 24 months) suggest structural cash needs
  • Q3 operating loss of $3.4M indicates the business is not yet self-sustaining
  • Massive overhang from 21.7M convertible note shares and 9.4M warrants

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001493152-26-051966
Document: 0001493152-26-051966-index-headers.html0001493152-26-051966
Document: 0001493152-26-051966-index.html0001493152-26-051966
Document: 0001493152-26-051966.txt0001493152-26-051966

Track record

15 reports on MEDS

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +35.05% at T+60 after the Aug 18, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 17, 2026today 424B5 Bearish 6/10 Entry price pending
  2. Nov 17, 2026today 8-K Bearish 7/10 Entry $0.6151 Now $0.6403 −4.10% settles Nov 25
  3. Nov 16, 20261d ago 424B5 Bearish 5/10 Viewing Entry $0.6421 Now $0.6403 +0.28% settles Nov 23
  4. Nov 16, 20261d ago 8-K Neutral 3/10 Entry $0.6421 Now $0.6403 −0.28% settles Nov 23
  5. Nov 13, 20264d ago 8-K Neutral 5/10 Entry $0.6421 Now $0.6403 −0.28% settles Nov 23
  6. Nov 10, 20266d ago SC 13G Neutral 4/10 Entry $0.9531 Now $0.6403 −32.82% settles Nov 18
  7. Nov 10, 20267d ago S-1/A Bearish 6/10 Entry $0.9531 Now $0.6403 +32.82% settles Nov 18
  8. Nov 5, 202612d ago 8-K Neutral 4/10 Entry $1.22 to $0.8702 Now $0.6403 −47.52% ▼ −28.67% −31.96% vs SPY
  9. Oct 26, 202622d ago 8-K Bearish 6/10 Entry $2.06 to $1.80 Now $0.6403 +68.92% ▲ +12.62% +10.63% vs SPY
  10. Oct 20, 202628d ago 8-K Neutral 4/10 Entry $2.75 to $2.06 Now $0.6403 −76.72% ▼ −25.09% −25.17% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 16, 2026